R&D

SML Biopharm is the next generation vaccine
It's a research and development company

Platform

mRNA Vaccine Information

SML Biopharm have mRNA platform with optimized UTR and poly(A) tail for enhanced stability and expression.
We are advancing drug pipelines and a next-generation mRNA platform, while independently developing
lipid nanoparticles (LNPs)
for efficient delivery, driving effective R&D and rapid progress in the field.